Structural Convergence in Immune Receptor Repertoires

You are reading version 1 of this direction, frozen 2026-10-04. The latest version is version 2.

Version 1 of 226 papers33 conceptsfrozen 2026-10-04

The human immune system is theoretically capable of generating billions of unique B-cell and T-cell receptors. For decades, researchers viewed this diversity as a vast, stochastic ocean where each individual’s immune response was a "private" event, unique to their genetic history. However, recent large-scale structural analyses reveal a surprising hidden order: while our immune sequences are 99.9% unique, our immune shapes are remarkably shared.

This phenomenon, known as structural convergence, suggests that the immune system relies on a conservative "structural vocabulary" to recognize pathogens. By shifting focus from genetic sequences to three-dimensional geometries, researchers are discovering that immune responses are far more predictable and universal than previously imagined.

The Sequence Structure Paradox

If you sequence the B-cell receptors (BCRs) of two different people, you will find almost no overlap. Yet, both individuals might successfully neutralize the same virus using the same biochemical strategy. This is the sequence-structure paradox: the immune system frequently achieves identical functional solutions through diverse genetic pathways.

Work by Aleksandr Kovaltsuk, Konrad Krawczyk, and colleagues in Structurally Mapping Antibody Repertoires demonstrated this by applying the SAAB (Structural Annotation of Antibodies) pipeline to millions of sequences. They found that the human immune system prefers a highly limited set of backbone geometries. In fact, Matthew I. J. Raybould and Charlotte Deane showed that structural commonality across individuals is roughly 100 times higher than sequence-based estimates.

This suggests that the "naïve" immune system starts with a universal structural toolkit. As Marie Ghraichy noted in studies of repertoire maturation, while antibodies become more personalized as we age, they still evolve toward a limited range of effective geometric solutions to neutralize common threats.

Public Repertoires and Degenerate Motifs

The evidence for this convergence is most striking in "public" repertoires—identical or near-identical receptor sequences found across unrelated people. In celiac disease, Louise F. Risnes and Asbjørn Christophersen found that pathogenic T-cell "blueprints" persist for decades and are shared across patients. Similarly, Shiva Dahal‐Koirala identified a dominant "R-motif" in gluten-specific receptors, proving that the immune response to specific triggers is highly stereotyped.

This predictability isn't limited to identical sequences. It also exists in "degenerate" patterns—short, conserved amino acid motifs that allow different receptors to "see" the same target. Yuxin Sun and Katharine Best used machine learning to show that deconstructing receptors into short triplets can predict immunization status with high accuracy, even when full sequences differ. By focusing on these K-mers (short motifs), researchers like S H Rahman have found significantly higher overlap between individuals than full-chain analysis would suggest.

From Clonotypes to Paratypes

Traditional immunology groups antibodies by clonotype—their genetic lineage. However, structural convergence implies that antibodies from completely different lineages can target the same site (epitope).

To capture this, Eve Richardson and Dominic F. Kelly proposed paratyping. This method groups antibodies by their predicted binding sites (paratopes) rather than their ancestry. Paratyping allows scientists to "hop" between different genetic scaffolds to find antibodies that are functionally identical but perhaps easier to manufacture or less likely to cause side effects.

This structural lens has been vital in responding to emerging threats. During the COVID-19 pandemic, Sarah A. Robinson and Claire Marks used computational modeling to show that the immune response to coronaviruses is highly convergent, with diverse genetic lineages adopting identical 3D geometries to neutralize the virus.

Predicting the Immune Future

Understanding these shared structural constraints allows us to predict how the immune system will behave.

  • Deep Learning: John-William Sidhom developed DeepTCR, which uses deep learning to identify shared receptor motifs that predict whether a patient will respond to cancer immunotherapy.
  • Mutation Profiles: Amrit Dhar and Vladimir N. Minin created SPURF, a tool that uses public repertoire data to predict "allowed" mutations in an antibody, helping engineers modify proteins without losing function.

Ultimately, the discovery of structural convergence transforms the immune system from a black box of random sequences into a map of predictable, geometric solutions. As we get better at reading this "structural vocabulary," we move closer to universal diagnostics and vaccines that leverage the shared blueprints of human immunity.

Papers in this version

History & citationVersion 2 · 2026-10-04

Current · Permanent link

  1. Version 2 (latest) · 2026-10-04 · 49 papers
  2. Version 1 · 2026-10-04 · 26 papers
Cite this direction

Latest version (a living page):

@misc{lacuna_convergent_immune_response_dd91f00b,
  title = {convergent immune response},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/convergent-immune-response/rdr_dd91f00be30846e8afd4e520a514380b},
  note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}

This exact version (version 1, frozen text):

@misc{lacuna_structural_convergence_in_immune_recepto_dd91f00b_v1,
  title = {Structural Convergence in Immune Receptor Repertoires},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/structural-convergence-in-immune-receptor-repertoires/rdr_dd91f00be30846e8afd4e520a514380b/v/1},
  note = {Version 1, frozen 2026-10-04. Accessed 2026-11-19},
}